Patents by Inventor Hans Zahner

Hans Zahner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5874262
    Abstract: A microbiological process for the preparation of N,N'-ethylenediaminedisuccinic acid of formula (1), by (a) precultivation of a strain of the genus Amycolatopsis orientalis on a specified nutrient medium (1st preculture), (b) inoculation of a nutrient solution of the same composition as the base of the production fermenter by the 1st preculture (2nd preculture), (c) inoculation of the base nutrient solution in the production fermenter with the 2nd preculture and incubation in accordance with a specified timetable, (d) feeding of the production fermenter in the fed-batch process with a feeding solution under aerobic conditions at a pH of from 2 to 8 and at a temperature of from 15.degree. to 40.degree. C., wherein the base nutrient and feeding solutions are free of zinc-containing compounds, is described. The compound prepared by the process according to the invention is suitable as complexing agent with good biodegradability in detergents.
    Type: Grant
    Filed: November 17, 1997
    Date of Patent: February 23, 1999
    Assignee: Ciba Specialty Chemicals Corporation
    Inventors: Hans Zahner, Ingeborg Cebulla, Michael Harder
  • Patent number: 5231013
    Abstract: A new polycyclic peptide antibiotic termed gallidermin is disclosed and described, together with a process for producing such antibiotic by fermination of a new microorganism, Staphylococcus gallinarum (DSM 4616).
    Type: Grant
    Filed: May 18, 1989
    Date of Patent: July 27, 1993
    Inventors: Gunther Jung, Roland Kellner, Hans Zahner, Friedrich Gotz, Thomas Horner, Rolf G. Werner, Hermann Allgaier
  • Patent number: 5079263
    Abstract: R.sup.2 is H or OH;R.sup.3 is H, OH, OCH.sub.3, CH.sub.3 or NH.sub.2 ;Rhu 4 is H, OH, OCH.sub.3, NH.sub.2 or ##STR2## The compounds of the formula I are prepared by fermentation of the strain Streptomyces parvulus DSM 40722 in the presence of substituted benzoic acids of the general formula II ##STR3## where R.sup.1 is H or OH;R.sup.2 is H or OH;R.sup.3 is H, OH, OCH.sub.3, CH.sub.3 or NH.sub.2 ;R.sup.4 is H, OH, OCH.sub.3 or NH.sub.2,and they inhibit Leukocyte elastase and can be used as pharmaceuticals.
    Type: Grant
    Filed: December 2, 1988
    Date of Patent: January 7, 1992
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Axel Zeeck, Ralf Thiericke, Hans Zahner, Gerhard Dickneite, Hans H. Sedlacek
  • Patent number: 4939125
    Abstract: The O-acyl derivatives of urdamycin A exhibit an antibiotic or antitumoral activity.
    Type: Grant
    Filed: October 5, 1987
    Date of Patent: July 3, 1990
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Axel Zeeck, Thomas Ciesiolka, Hans Zahner, Hannelore Drautz
  • Patent number: 4859655
    Abstract: A new substance, urdamycin G, has been found which, like its O-acyl derivatives, exhibits an antibiotic or antitumoral activity.
    Type: Grant
    Filed: August 26, 1987
    Date of Patent: August 22, 1989
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Axel Zeeck, Thomas Ciesiolka, Jurgen Rohr, Hans Zahner, Hannelore Drautz
  • Patent number: 4585761
    Abstract: A method of combating arthropods, comprising applying to the arthropods, or to a habitat infested therewith an arthropodicidally effective amount of an antibiotic which (a) is colorless, very readily soluble in water and in pyridine but insoluble in other customary organic solvents, gives a positive reaction with ninhydrin, sodium metaperiodate/benzidine and potassium permanganate and gives a yellow coloration with iron (III) chloride, (b) has the UV and IR spectra substantially as shown in FIGS. 1 and 2, (c) on chemical degradation yields uracil, an amino-hexuronic acid and an amino-acid containing a pyridine ring, (d) on paper electrophoresis proves to be an amphoteric substance and has an isoelectric point at about pH 6 and (e) consists of the elements carbon, hydrogen, oxygen and nitrogen, or one or more active components of the antibiotic mixture, the active agent being applied alone or in admixture with a diluent or carrier.
    Type: Grant
    Filed: May 20, 1981
    Date of Patent: April 29, 1986
    Assignee: Ciba Geigy AG
    Inventors: Hans Zahner, Hartwig Holst, Gerhard Zoebelein, Adelinde Keckeisen
  • Patent number: 4558139
    Abstract: Bafilomycins of the formula ##STR1## in which R.sup.1 is hydrogen or CH.sub.3, andR.sup.2 is hydrogen, or the group ##STR2## are produced by culturing certain streptomyces, e.g. Tu 1922, Tu 2437 and Tu 2599. Those wherein at least one of the OH groups is acylated are new. The compounds are pesticidally active.
    Type: Grant
    Filed: March 14, 1984
    Date of Patent: December 10, 1985
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Paul Hagenmaier, Gerhard Werner, Hannelore Drautz, Hartwig Holst, Hans Zahner, Wilhelm Brandes, Paul Reinecke, Gerhard Zoebelein, Wilhelm Stendel, Peter Andrews, Klaus Schaller
  • Patent number: 4406905
    Abstract: The invention relates especially to 2-(3'-hydroxypyrid-2'-yl)-2-thiazoline-4-carboxylic acid derivatives of the formula (I) and salts and also certain metal complexes of these compounds, processes for their manufacture, pharmaceutical agents containing such compounds and the use of these compounds. ##STR1## In the formula, R.sup.1 represents free, etherified or esterified hydroxy, R.sup.2 represents hydrogen or an aliphatic, carbocyclic or carbocyclic-aliphatic radical having 1-12 carbon atoms, and R.sup.3 represents hydrogen or an unsubstituted aliphatic radical having 1-7 carbon atoms.The compounds of the formula (I) can be used, for example, for the abstraction of heavy metals from the organism of warm-blooded animals and/or they have an antibiotic action.
    Type: Grant
    Filed: July 23, 1981
    Date of Patent: September 27, 1983
    Assignee: Ciba-Geigy Corporation
    Inventors: Hans Zahner, Hans-Ulrich Naegeli, Heinrich Peter
  • Patent number: 4315922
    Abstract: Pesticidally active substantially pure nikkomicin fractions obtained from Streptomyces tendae Ettlinger et al Tu 901, the fractions being selected from the group consisting of ##STR1## a mixture of nikkomicin I and J, and a mixture of nikkomicin M and N.
    Type: Grant
    Filed: July 10, 1980
    Date of Patent: February 16, 1982
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Paul Hagenmaier, Wilfried Konig, Hans Zahner, Hans-Peter Fiedler, Wolfgang Dehler, Adelinde Keckeisen, Hartwig Holst, Gerhard Zoebelein
  • Patent number: 4287186
    Abstract: A method of combating arthropods, comprising applying to the arthropods, or to a habitat infested therewith an arthropodicidally effective amount of an antibiotic which (a) is colorless, very readily soluble in water and in pyridine but insoluble in other customary organic solvents, gives a positive reaction with ninhydrin, sodium metaperiodate/benzidine and potassium permanganate and gives a yellow coloration with iron (III) chloride, (b) has the UV and IR spectra substantially as shown in FIGS. 1 and 2, (c) on chemical degradation yields uracil, an amino-hexuronic acid and an amino-acid containing a pyridine ring, (d) on paper electrophoresis proves to be an amphoteric substance and has an isolectric point at about pH 6 and (e) consists of the elements carbon, hydrogen, oxygen and nitrogen, or one or more active components of the antibiotic mixture, the active agent being applied alone or in admixture with a diluent or carrier.
    Type: Grant
    Filed: December 21, 1979
    Date of Patent: September 1, 1981
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans Zahner, Hartwig Holst, Gerhard Zoebelein, Adelinde Keckeisen
  • Patent number: 4277478
    Abstract: The invention relates to the new antibiotic Lysolipin including two components X and I, and derivatives thereof. Lysolipin is formed when the strain Streptomyces violaceoniger (Waksman et Curtis) Waksman et Henrici Tu 96, which strain has been deposited under the reference NRRL 8097 at the Northern Regional Laboratory, U.S. Department of Agriculture, Peoria, Illinois, is cultured in a nutrient medium. The structural formulae of the 2 components are ##STR1## Lysolipin I and X and their derivatives have antibacterial activity and are effective against yeast - like fungi, such as Candida albicans. Their antibiotic action probably depends on an inhibition of the cell wall synthesis.
    Type: Grant
    Filed: May 21, 1979
    Date of Patent: July 7, 1981
    Assignee: Ciba-Geigy Corporation
    Inventors: Hans Zahner, Hannelore Drautz, Walter Keller
  • Patent number: 4211787
    Abstract: The invention provides compositions containing cladosporin and/or analogs of cladosporin. Said composition in the form of treated feed compositions or treated drinking water promote and accelerate the growth of animals and improve feedstuff utilization.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: July 8, 1980
    Assignee: Bayer Aktiengesellschaft
    Inventors: Martin Scheer, Heidrun Anke, Wilfried Konig, Hans Zahner
  • Patent number: 4158608
    Abstract: The new antibiotic Nikkomycin is produced by culturing the strain Streptomyces tendae Ettlinger et al Tu 901 in a nutrient medium at a pH of about 5.5 to 8 under aerobic conditions and isolation by cation exchange from the culture filtrate, followed by elution. The antibiotic is believed to have the structural formula ##STR1## and is characterized by fungicidal activity.
    Type: Grant
    Filed: April 7, 1977
    Date of Patent: June 19, 1979
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ursula Dahn, Hanspaul Hagenmaier, Helmut Hohne, Wilfried Konig, Hans Scheinpflug, Hans Zahner
  • Patent number: 4046881
    Abstract: The new antibiotic Nikkomycin is produced by culturing the strain Streptomyces tendae Ettlinger et al Tu 901 in a nutrient medium at a pH of about 5.5 to 8 under aerobic conditions and isolation by cation exchange from the culture filtrate, followed by elution. The antibiotic is believed to have the structural formula ##STR1## and is characterized by fungicidal activity.
    Type: Grant
    Filed: March 24, 1976
    Date of Patent: September 6, 1977
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ursula Dahn, Hanspaul Hagenmaier, Helmut Hohne, Wilfried Konig, Hans Scheinpflug, Hans Zahner